DARPA taps NeuroPace for memory loss trial

NeuroPace teams up with the Defense Advanced Research Projects Agency to examine use of implanted neurostimulators to help restore memory.

Epilepsy treatment devices maker NeuroPace hopes to expand its clinical applications by supporting a research initiative to evaluate neurostimulation implants in treatment of memory deficits.

Defense Advanced Research Projects Agency (DARPA), NeuroPace

News Well, Clinical Trials, Neurological, Neuromodulation/Neurostimulation, Research & Development

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tAHs78